ODELAM, rapid sequence-independent detection of drug resistance in isolates of
Antibiotics, Antitubercular
/ pharmacology
Colony Count, Microbial
Drug Resistance, Multiple, Bacterial
/ genetics
Humans
Kinetics
Microbial Sensitivity Tests
Microscopy, Video
Mycobacterium tuberculosis
/ drug effects
Ofloxacin
/ pharmacology
Predictive Value of Tests
Reproducibility of Results
Time-Lapse Imaging
Tuberculosis, Multidrug-Resistant
/ diagnosis
Workflow
Mycobacterium tuberculosis
drug resistance
growth phenotype
heterogeneity
infectious disease
microbiology
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
13 05 2020
13 05 2020
Historique:
received:
03
03
2020
accepted:
12
05
2020
pubmed:
14
5
2020
medline:
18
3
2021
entrez:
14
5
2020
Statut:
epublish
Résumé
Antimicrobial-resistant
Identifiants
pubmed: 32401195
doi: 10.7554/eLife.56613
pii: 56613
pmc: PMC7263823
doi:
pii:
Substances chimiques
Antibiotics, Antitubercular
0
Ofloxacin
A4P49JAZ9H
Banques de données
Dryad
['10.5061/dryad.b8gtht78q']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : U19 AI162598
Pays : United States
Organisme : NIH HHS
ID : R56 AI118361
Pays : United States
Organisme : NIH HHS
ID : P41 GM109824
Pays : United States
Organisme : NIH HHS
ID : R01 AI063200
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111276
Pays : United States
Organisme : NIH HHS
ID : R01 AI141953
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135976
Pays : United States
Informations de copyright
© 2020, Herricks et al.
Déclaration de conflit d'intérêts
TH, MD, FM, TR, RM, TS, DS, JA No competing interests declared
Références
J Antimicrob Chemother. 2012 Apr;67(4):819-31
pubmed: 22279180
Tuberculosis (Edinb). 2016 May;98:110-5
pubmed: 27156626
J Infect Dis. 2018 Nov 5;218(12):1974-1982
pubmed: 30085153
Science. 2013 Jan 4;339(6115):91-5
pubmed: 23288538
Nature. 2006 Jan 5;439(7072):100-104
pubmed: 16397501
Clin Microbiol Rev. 2015 Jan;28(1):191-207
pubmed: 25567227
Nat Methods. 2008 Jan;5(1):19-21
pubmed: 18165803
J Biol Methods. 2014;1(2):
pubmed: 25606571
Emerg Infect Dis. 2001 Mar-Apr;7(2):337-41
pubmed: 11294736
J Clin Microbiol. 2007 Jun;45(6):1766-70
pubmed: 17442793
J Mol Biol. 1994 Sep 30;242(4):351-63
pubmed: 7932695
BMC Res Notes. 2013 May 30;6:215
pubmed: 23721428
J Antimicrob Chemother. 2016 Sep;71(9):2419-27
pubmed: 27261264
Tuberculosis (Edinb). 2012 Nov;92(6):489-96
pubmed: 22954584
J Microbiol Methods. 2004 Feb;56(2):291-4
pubmed: 14744458
Science. 2012 Jan 6;335(6064):100-4
pubmed: 22174129
Elife. 2020 May 13;9:
pubmed: 32401195
Cell Host Microbe. 2013 Jun 12;13(6):632-42
pubmed: 23768488
J Biol Chem. 1999 Aug 6;274(32):22747-54
pubmed: 10428858
Braz J Microbiol. 2013 May 31;44(1):287-9
pubmed: 24159318
Front Microbiol. 2019 Apr 16;10:706
pubmed: 31057494
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27895008
G3 (Bethesda). 2017 Jan 5;7(1):279-288
pubmed: 27856698
Methods Enzymol. 2010;470:145-79
pubmed: 20946810
Antimicrob Agents Chemother. 2014 Jun;58(6):3270-5
pubmed: 24687490
Sci Transl Med. 2014 Dec 17;6(267):267ra174
pubmed: 25520395
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9
pubmed: 11416222
Nat Rev Genet. 2019 Jun;20(6):356-370
pubmed: 30886350
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Clin Invest. 2011 Mar;121(3):1119-29
pubmed: 21317536
Lancet Infect Dis. 2018 Jan;18(1):76-84
pubmed: 29198911
EMBO Rep. 2009 Aug;10(8):929-33
pubmed: 19556999
PLoS One. 2014 Jan 21;9(1):e85177
pubmed: 24465499
Antimicrob Agents Chemother. 2009 Feb;53(2):821-3
pubmed: 19029320
Eur Respir J. 2005 Mar;25(3):564-9
pubmed: 15738303
Nucleic Acids Res. 2002 May 15;30(10):2144-53
pubmed: 12000834
J Biol Chem. 1996 Oct 18;271(42):26424-9
pubmed: 8824300
G3 (Bethesda). 2016 Sep 08;6(9):3003-14
pubmed: 27371952